The Guardian · US news · Original story
US voters support HIV/Aids relief – will Trump’s cuts backfire in the midterms?
Global Pepfar program has long had Republican leadership and bipartisan support, but initiative is under fire
US midterm voters overwhelmingly support Pepfar, an initiative to end HIV/Aids that also has strengthened health systems against other infectious disease threats but has come under fire from the Trump administration.
About three in four (74%) of likely voters in the US midterm elections say they support funding the US President’s Emergency Plan for AIDS Relief (Pepfar), with voters more likely to back candidates who support Pepfar, according to a recent poll. Four in five (80%) of the voters said there is a moral argument for supporting lifesaving treatment for people at risk for or living with HIV/Aids, regardless of their personal choices.
Continue reading...
Melody Schreiber · Sun, May 24, 2026, 5:00 AM
US news | The Guardian
Global Pepfar program has long had Republican leadership and bipartisan support, but initiative is under fire
US midterm voters overwhelmingly support Pepfar, an initiative to end HIV/Aids that also has strengthened health systems against other infectious disease threats but has come under fire from the Trump administration.
About three in four (74%) of likely voters in the US midterm elections say they support funding the US President’s Emergency Plan for AIDS Relief (Pepfar), with voters more likely to back candidates who support Pepfar, according to a recent poll. Four in five (80%) of the voters said there is a moral argument for supporting lifesaving treatment for people at risk for or living with HIV/Aids, regardless of their personal choices.
Continue reading...This page shows an excerpt; reporting belongs to the original publisher. Some images or embeds may be omitted compared with the live article.
← More stories · Front page
